Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zentalis Pharmaceuticals (ZNTL)
NASDAQ:ZNTL
RESEARCH TOOLSreports
Holding ZNTL?
Track your performance easily
See the Price Targets and Ratings of:
ZNTL Analyst Ratings
Moderate Buy
4 Buy
5 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ZNTL Stock 12 Month Forecast
Average Price Target
$10.70
▲(168.84% Upside)
| Highest Price Target$25.00 | Average Price Target$10.70 | Lowest Price Target$4.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Guggenheim
Reiterated
06/20/24
Leerink Partners
Reiterated
06/19/24
H.C. Wainwright
Reiterated
06/18/24
Jefferies
Downgraded
06/18/24
Wells Fargo
Downgraded
06/18/24
Stifel Nicolaus
Reiterated
06/18/24
Wedbush
Downgraded
06/18/24
Morgan Stanley
Downgraded
06/18/24
Oppenheimer
Reiterated
06/18/24
TD Cowen
―
Buy
―
Reiterated
02/27/24
TD Cowen Keeps Their Buy Rating on Zentalis Pharmaceuticals (ZNTL)
Best Analysts Covering Zentalis Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy ZNTL and Sell After:
1 Month
xxx
Success Rate
4/12 ratings generated profit
Average Return
-12.08%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 33.33% of your transactions generating a profit, with an average return of -12.08% per trade.
3 Months
xxx
Success Rate
6/12 ratings generated profit
Average Return
-15.96%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -15.96% per trade.
1 Year
Success Rate
0/9 ratings generated profit
Average Return
-47.67%
reiterated a buy rating 6 months ago
Copying Andrew Fein's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -47.67% per trade.
2 Years
xxx
Success Rate
0/9 ratings generated profit
Average Return
-69.31%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -69.31% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ZNTL Analyst Recommendation Trends
Rating
Nov 23
Jan 24
Feb 24
May 24
Jun 24
Strong Buy
17
13
11
6
11
Buy
2
1
2
1
1
Hold
2
3
5
4
8
Sell
0
0
0
0
1
Strong Sell
0
0
0
0
0
total
21
17
18
11
21
Each month's total comprises the sum of three months' worth of ratings.
ZNTL Financial Forecast
ZNTL Stock Forecast FAQ
What is ZNTL’s average 12-month price target, according to analysts?
Based on analyst ratings, Zentalis Pharmaceuticals’s 12-month average price target is $10.70.
What is ZNTL’s upside potential, based on the analysts’ average price target?
Zentalis Pharmaceuticals has 168.84% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ZNTL a Buy, Sell or Hold?
Zentalis Pharmaceuticals has a consensus rating of Moderate Buy which is based on 4 buy ratings, 5 hold ratings and 1 sell ratings.
What is Zentalis Pharmaceuticals’s price target?
The average price target for Zentalis Pharmaceuticals is $10.70. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $25.00 ,the lowest forecast is $4.00. The average price target represents 168.84% Increase from the current price of $3.98.
The highest analyst price target is $25.00 ,the lowest forecast is $4.00. The average price target represents 168.84% Increase from the current price of $3.98.
What do analysts say about Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of ZNTL?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.